These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6848747)

  • 1. Single-pass removal of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung, in vivo: kinetics and sites of removal.
    Catravas JD; Gillis CN
    J Pharmacol Exp Ther; 1983 Jan; 224(1):28-33. PubMed ID: 6848747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary extraction of [3H]bupivacaine: modification by dose, propranolol and interaction with [14C]5-hydroxytryptamine.
    Rothstein P; Cole JS; Pitt BR
    J Pharmacol Exp Ther; 1987 Feb; 240(2):410-4. PubMed ID: 3806406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of pulmonary microvascular endothelial angiotensin-converting enzyme in vivo: comparison of three probes.
    Orfanos SE; Chen XL; Ryan JW; Chung AY; Burch SE; Catravas JD
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):99-111. PubMed ID: 8291066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of serotonin uptake in cultured pheochromocytoma cells. Comparison with norepinephrine uptake.
    Yoffe JR; Borchardt RT
    Mol Pharmacol; 1982 Mar; 21(2):368-73. PubMed ID: 7099140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species variation in pulmonary endothelial aminopeptidase P activity.
    Chen X; Orfanos SE; Ryan JW; Chung AY; Hess DC; Catravas JD
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1301-7. PubMed ID: 1762077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective effect of microembolization on pulmonary removal of biogenic amines.
    Flink JR; Pitt BR; Hammond GL; Gillis CN
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Feb; 52(2):421-7. PubMed ID: 7061295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enflurane, halothane, and isoflurane inhibit removal of 5-hydroxytryptamine from the pulmonary circulation.
    Cook DR; Brandom BW
    Anesth Analg; 1982 Aug; 61(8):671-5. PubMed ID: 7201270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthine oxidase-induced lung injury inhibits removal of 5-hydroxytryptamine from the pulmonary circulation.
    Cook DR; Howell RE; Gillis CN
    Anesth Analg; 1982 Aug; 61(8):666-70. PubMed ID: 6283949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacodynamics of 5-hydroxytryptamine uptake and metabolism by the isolated perfused rabbit lung.
    Pickett RD; Anderson MW; Orton TC; Eling TE
    J Pharmacol Exp Ther; 1975 Sep; 194(3):545-53. PubMed ID: 1159631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary disposition and effects of drugs on pulmonary removal of endogenous substances.
    Mehendale HM
    Fed Proc; 1984 Aug; 43(11):2586-91. PubMed ID: 6204891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary endothelial dysfunction in the presence or absence of interstitial injury induced by intratracheally injected bleomycin in rabbits.
    Catravas JD; Lazo JS; Dobuler KJ; Mills LR; Gillis CN
    Am Rev Respir Dis; 1983 Oct; 128(4):740-6. PubMed ID: 6194726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pulmonary and extrapulmonary extraction of biogenic amines.
    Pitt BR; Hammond GL; Gillis CN
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Jun; 52(6):1545-51. PubMed ID: 7050061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of radioiodinated benzylguanidines in perfused rabbit lung: pharmacokinetics and effect of an organo-gold complexed antineoplastic agent.
    Weng WL; Lazo JS; Gillis CN; Pitt BR
    J Pharmacol Exp Ther; 1990 Oct; 255(1):59-65. PubMed ID: 2213571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters.
    Daws LC; Toney GM; Gerhardt GA; Frazer A
    J Pharmacol Exp Ther; 1998 Aug; 286(2):967-76. PubMed ID: 9694957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
    Kihara T; Ikeda M
    J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of bleomycin toxicity: clearance of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung in vivo.
    Catravas JD; Lazo JS; Gillis CN
    J Pharmacol Exp Ther; 1981 May; 217(2):524-9. PubMed ID: 6164780
    [No Abstract]   [Full Text] [Related]  

  • 18. Propranolol and serotonin removal in lung injury.
    Merker MP; Gillis CN
    J Appl Physiol (1985); 1988 Dec; 65(6):2579-84. PubMed ID: 3063711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1980 Jan; 212(1):97-102. PubMed ID: 7351629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between parathion and paraoxon toxicokinetics, lung metabolic activity, and cholinesterase inhibition in guinea pig and rabbit lungs.
    Lessire F; Gustin P; Delaunois A; Bloden S; Nemmar A; Vargas M; Ansay M
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):201-10. PubMed ID: 8658521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.